Skip to main content
. 2013 Aug 13;57(10):1438–1448. doi: 10.1093/cid/cit536

Figure 2.

Figure 2.

Mayo Clinic guidelines for the management of left ventricular assist device (LVAD)–associated infections (LVADIs). Guidelines are referenced from [23–25]. These are general guidelines only, and LVADI management should be individualized based on clinical presentation and host factors. aChronic suppressive antimicrobial therapy is highly recommended if there is (1) failure to clear bloodstream infection (BSI) despite appropriate antibiotic therapy or removal of the suspect catheter in the setting of catheter-related BSI or (2) relapse of BSI after completing an appropriate antibiotic course, but it should ultimately be guided by clinical judgment. Abbreviations: AHA, American Heart Association; BSI, bloodstream infection; CIED, cardiovascular implantable electronic device; CVC, central venous catheter; IDSA, Infectious Diseases Society of America; IE, infective endocarditis; LVADI, left ventricular assist device–associated infections; TEE, transesophageal echocardiography; VAD, ventricular assist device.